264 related articles for article (PubMed ID: 26060322)
1. Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Manivel VA; Lysholm J; Knight A; Rönnelid J
Rheumatology (Oxford); 2015 Oct; 54(10):1923-8. PubMed ID: 26060322
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
[TBL] [Abstract][Full Text] [Related]
3. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
4. Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis.
Ruge T; Södergren A; Wållberg-Jonsson S; Larsson A; Arnlöv J
Scand J Rheumatol; 2014; 43(5):371-3. PubMed ID: 24825074
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease Activity.
Arntz OJ; Pieters BCH; Thurlings RM; Wenink MH; van Lent PLEM; Koenders MI; van den Hoogen FHJ; van der Kraan PM; van de Loo FAJ
Front Immunol; 2018; 9():2388. PubMed ID: 30420853
[TBL] [Abstract][Full Text] [Related]
6. Correlation between rheumatoid factor and IL-6 activity in synovial fluids from patients with rheumatoid arthritis.
Sawada T; Hirohata S; Inoue T; Ito K
Clin Exp Rheumatol; 1991; 9(4):363-8. PubMed ID: 1934684
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
[TBL] [Abstract][Full Text] [Related]
8. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage.
Fojtíková M; Tomasová Studýnková J; Filková M; Lacinová Z; Gatterová J; Pavelka K; Vencovský J; Senolt L
Clin Exp Rheumatol; 2010; 28(6):849-54. PubMed ID: 21122264
[TBL] [Abstract][Full Text] [Related]
9. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serological markers between ACPA⁺ and ACPA⁻ of RA patients.
Xun C; Zhao Y
Rheumatol Int; 2012 May; 32(5):1143-6. PubMed ID: 21246364
[TBL] [Abstract][Full Text] [Related]
11. Interactions between smoking, increased serum levels of anti-CCP antibodies, rheumatoid factors, and erosive joint disease in patients with early, untreated rheumatoid arthritis.
Krol A; Garred P; Heegaard NH; Christensen AF; Hetland ML; Stengaard-Pedersen K; Junker P; Madsen HO; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Pedersen JK; Svendsen AJ; Tarp U; Pødenphant J; Lindegaard H; Østergaard M; Hørslev-Petersen K; Jacobsen S
Scand J Rheumatol; 2015; 44(1):8-12. PubMed ID: 25205362
[TBL] [Abstract][Full Text] [Related]
12. Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study.
Nell-Duxneuner V; Machold K; Stamm T; Eberl G; Heinzl H; Hoefler E; Smolen JS; Steiner G
Ann Rheum Dis; 2010 Jan; 69(1):169-74. PubMed ID: 19153104
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
Weitoft T; Larsson A; Saxne T; Manivel VA; Lysholm J; Knight A; Rönnelid J
Scand J Rheumatol; 2017 Sep; 46(5):346-352. PubMed ID: 27973973
[TBL] [Abstract][Full Text] [Related]
14. [Clinical value of serum matrix metalloproteinase-3 in evaluating joint destruction and therapeutic effect in rheumatoid arthritis patients].
Li L; Cai B; Liao J; Yang B; Huang Z; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Sep; 29(9):966-9. PubMed ID: 24011160
[TBL] [Abstract][Full Text] [Related]
15. Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritis.
Scarsi M; Paolini L; Ricotta D; Pedrini A; Piantoni S; Caimi L; Tincani A; Airò P
J Rheumatol; 2014 Apr; 41(4):666-72. PubMed ID: 24584924
[TBL] [Abstract][Full Text] [Related]
16. Anti-CCP and RF IgM: predictors of impaired endothelial function in rheumatoid arthritis patients.
Hjeltnes G; Hollan I; Førre Ø; Wiik A; Mikkelsen K; Agewall S
Scand J Rheumatol; 2011 Nov; 40(6):422-7. PubMed ID: 22150462
[TBL] [Abstract][Full Text] [Related]
17. Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
Kastbom A; Roos Ljungberg K; Ziegelasch M; Wetterö J; Skogh T; Martinsson K
Clin Exp Immunol; 2018 Dec; 194(3):391-399. PubMed ID: 30136282
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
Aletaha D; Alasti F; Smolen JS
Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
[TBL] [Abstract][Full Text] [Related]
19. The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
Willemze A; Shi J; Mulder M; Stoeken-Rijsbergen G; Drijfhout JW; Huizinga TW; Trouw LA; Toes RE
Ann Rheum Dis; 2013 Jun; 72(6):1059-63. PubMed ID: 23486413
[TBL] [Abstract][Full Text] [Related]
20. Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.
Mjaavatten MD; van der Heijde DM; Uhlig T; Haugen AJ; Nygaard H; Bjørneboe O; Kvien TK
J Rheumatol; 2011 Nov; 38(11):2336-41. PubMed ID: 21965645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
